home libri books Fumetti ebook dvd top ten sconti 0 Carrello


Torna Indietro

hoffman daniel; bowditch allan - the global pharmaceutical industry

The Global Pharmaceutical Industry The Demise and the Path to Recovery

;




Disponibilità: Normalmente disponibile in 20 giorni
A causa di problematiche nell'approvvigionamento legate alla Brexit sono possibili ritardi nelle consegne.


PREZZO
48,98 €
NICEPRICE
46,53 €
SCONTO
5%



Questo prodotto usufruisce delle SPEDIZIONI GRATIS
selezionando l'opzione Corriere Veloce in fase di ordine.


Pagabile anche con Carta della cultura giovani e del merito, 18App Bonus Cultura e Carta del Docente


Facebook Twitter Aggiungi commento


Spese Gratis

Dettagli

Genere:Libro
Lingua: Inglese
Editore:

Routledge

Pubblicazione: 04/2022
Edizione: 1° edizione





Note Editore

The pharmaceutical industry, long thought of as a recession-proof investment, now faces a day of reckoning. The reasons for this impending downfall are not hard to discern. The prices the industry charges for its prescription drugs have escalated at four to five times the cost-of-living increases during the past two decades and have reached a point where 30% of Americans must choose between filling a prescription, paying for housing, and buying food. This has brought about public pressure on governments around the world to control drug prices, yet the world’s twenty largest pharma companies realized 80% of their growth as a result of exorbitant price hikes. Pharma currently enjoys its extraordinary profitability by exploiting the world’s most vulnerable populations. Yet even their ability to increase prices in the face of falling demand does not satisfy their profit demands. The breadth and depth of pharma’s marketing transgressions exceed those of any other industry and have now reached a point where authorities around the world have found it necessary to take legal action against its violations. Drastic change is needed if the pharmaceutical industry can equitably advance the health of the world’s population and regain public esteem. This book illustrates the range and extent of pharma’s violations and addresses the actions that should be implemented in order to make the drug industry a more constructive, less venal part of contemporary society. It will be of interest to researchers, academics, practitioners, and students with an interest in the pharmaceutical industry, healthcare management, regulation, and bioethics.




Sommario

1. From Family Businesses to Public Darling to the Monster Serving Wall Street; 2. Pharma’s Violations and Dirty Tricks; 3. The Economics of the Pharmaceutical Industry; 4. A Somnolent Public Awakens; 5. The Path Toward Reform;




Autore

Daniel Hoffman is the president of Pharmaceutical Business Research Associates (PBRA), USA. Allan Bowditch is the former CEO of Martin Hamblin Healthcare and a consultant to the pharmaceutical industry.










Altre Informazioni

ISBN:

9780367514235

Condizione: Nuovo
Collana: Routledge Advances in Management and Business Studies
Dimensioni: 9 x 6 in Ø 0.42 lb
Formato: Brossura
Illustration Notes:2 tables
Pagine Arabe: 130


Dicono di noi